During the past decade, Ehret Reinhard conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ehret Reinhard" are "Idiopathic Parkinson's Disease" (2 trials). Many other conditions were trialed in "Ehret Reinhard" in a lesser frequency.

Most popular intervention types in "Ehret Reinhard" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Matching Placebo" (1 trials), "Safinamide (as add-on therapy)" (1 trials) and "Safinimide 50-100 mg/day" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ehret Reinhard" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ehret Reinhard". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ehret Reinhard, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ehret Reinhard, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".